QR code

Maintenance therapy with oral decitabine plus cedazuridine after allogeneic stem cell transplantation for myelodysplastic syndrome

Disease relapse remains the primary challenge for patients undergoing allogeneic transplantation (HSCT) for myelodysplastic syndrome (MDS). Maintenance therapies with hypomethylating agents are under investigation for use in mitigating relapse in high-risk patients. In this retrospective study, we...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Portia Smallbone, Terri Lynn Shigle, Oren Paslovsky, Chitra Hosing, Amin Alousi, Qaiser Bashir, Yosra Aljawai, Jeremy Ramdial, Uday Popat, Richard Champlin, Elizabeth J. Shpall, Betül Oran
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Ferrata Storti Foundation 2025-02-01
Reeks:Haematologica
Online toegang:https://haematologica.org/article/view/11958
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!